title: Anti-VEGF treating macular oedema caused by retinal arteriovenous malformation - a case report.
authors.affiliation: Department of Ophthalmology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
authors.forename: Eva
authors.initials: E
authors.lastname: Winter
authors.forename: Tor
authors.initials: T
authors.lastname: Elsås
authors.forename: Dordi
authors.initials: D
authors.lastname: Austeng
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001165:Arteriovenous Malformations / Q000150:complications* / Q000175:diagnosis; D000068258:Bevacizumab; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008269:Macular Edema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012161:Retinal Artery / Q000002:abnormalities* / Q000473:pathology; D012169:Retinal Vein / Q000002:abnormalities* / Q000473:pathology; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab